Health behaviors of young adult heroin injectors in the Seattle area

Drug and Alcohol Dependence

Volumn 158, Issue , 2016, Pages 102-109

  Cedarbaum, Emily R ^a   Banta Green, Caleb J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Epidemiology; Heroin; Injection drug use; Syringe exchange; Young adult

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; COCAINE; DIAMORPHINE; FENTANYL; METHADONE; METHAMPHETAMINE; NALOXONE; OPIATE; SEDATIVE AGENT;

ABSCESS; ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; COTTON; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DRUG OVERDOSE; EDUCATION; FEMALE; HEALTH BEHAVIOR; HEALTH INSURANCE; HEALTH PROGRAM; HEPATITIS C; HEROIN DEPENDENCE; HOUSING; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; MEDICAL CARE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SYRINGE; SYRINGE EXCHANGE PROGRAM; UNITED STATES; YOUNG ADULT; ADOLESCENT; AGE; COHORT ANALYSIS; PREVENTIVE HEALTH SERVICE; PSYCHOLOGY; QUESTIONNAIRE; SELF REPORT; SUBSTANCE ABUSE; WASHINGTON;

ADOLESCENT; ADULT; AGE FACTORS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HEROIN DEPENDENCE; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; SELF REPORT; SUBSTANCE ABUSE, INTRAVENOUS; SURVEYS AND QUESTIONNAIRES; SYRINGES; WASHINGTON; YOUNG ADULT;

EID: 84952639480     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.11.011     Document Type: Article

References (33)

1. Atluri S., Sudarshan G., Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Phys. 2014, 17:E119-E128.
2. Bailey S.L., Ouellet L.J., Mackesy-Amiti M.E., Golub E.T., Hagan H., Hudson S.M., Latka M.H., Gao W., Garfein R.S. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007, 91(Suppl. 1):S18-S29. DUIT Study Team.
3. Banta-Green C. Info Brief: Heroin Trends Across Washington State 2013, Alcohol and Drug Abuse Institute, University of Washington, 〈http://adai.uw.edu/pubs/InfoBriefs/ADAI-IB-2013-02.pdf〉 (accessed March 30, 2014).
4. Banta-Green C., Jackson T.R., Freng S., Hanrahan M., Graff C., Reid S. Drug Abuse Trends in the Seattle/King County Area: 2012 2013, Alcohol and Drug Abuse Institute, University of Washington, Available at 〈http://adai.uw.edu/pubs/CEWG/CEWG_Seattle_June2013.pdf〉.
5. Banta-Green C., Jackson T.R., Freng S., Hanrahan M., Graff C., Ohta J., Taylor M., Harruff R., Smith R., Sylla L., Miller G., Couper F. Drug Abuse Trends in the Seattle/King County Area: 2013. 2014 2014, Alcohol and Drug Abuse Institute, University of Washington, 〈http://adai.washington.edu/pubs/cewg/CEWG_Seattle_June2014.pdf〉 (accessed on March 2, 2015).
6. Banta-Green C.J. Adolescent abuse of pharmaceutical opioids raises questions about prescribing and prevention. Arch. Pediatr. Adolesc. Med. 2012, 166:865-866.
7. Binswanger I.A., Blatchford P.J., Mueller S.R., Stern M.F. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann. Intern. Med. 2013, 159:592-600.
8. Centers for Disease Control and Prevention Rates of drug poisoning deaths involving heroin, by selected age and racial/ethnic groups-United States, 2002 and 2011. MMWR 2014, 63:595.
9. Cicero T.J., Ellis M.S., Surratt H.L., Kurtz S.P. The Changing face of heroin use in the United States. JAMA Psychiatry 2014, 71:821-826.
10. Coffin P.O., Sullivan S.D. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann. Intern. Med. 2013, 158:1-9.
11. Coffin P.O., Tracy M., Bucciarelli A., Ompad D., Vlahov D., Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad. Emerg. Med. 2007, 14:616-623.
12. Darke S., Williamson A., Ross J., Mills K.L., Havard A., Teesson M. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. J. Urban Health 2007, 84:283-291.
13. Farrell M., Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008, 103:251-255.
14. Golub E.T., Strathdee S.A., Bailey S.L., Hagan H., Latka M.H., Hudson S.M., Garfein R.S., DUIT Study Team Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007, 91(Suppl. 1):S30-S38.
15. Gordon R.J., Lowy F.D. Bacterial infections in drug users. N. Engl. J. Med. 2005, 353:1945-1954.
16. Hagan H., Thiede H., Weiss W.S., Hopkins S.G., Duchin J.S., Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 2001, 91:42-46.
17. Hosmer D.W., Lemeshow S. Applied Logistic Regression 2000, Wiley Inter-science, New York, NY. second ed.
18. Jenkins L.M., Banta-Green C.J., Maynard C., Kingston S., Hanrahan M., Merril J.O., Coffin P.O. Risk factors for nonfatal overdose at Seattle-area syringe exchanges. J. Urban Health 2011, 88:118-128.
19. Jones C.M. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013, 132:95-100.
20. Kral A.H., Lorvick J., Edlin B.R. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J. Acquir. Immune Defic. Syndr. 2000, 24:162-167.
21. Meier B. Tightening the Lid on Pain Prescriptions 2012, New York Times, Sect. A1.
22. Moss R., Munt B. Injection drug use and right sided endocarditis. Heart 2003, 89:77-81.
23. Ochoa K.C., Davidson P.J., Evans J.L., Hahn J.A., Page-Shafer K., Moss A.R. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005, 80:297-302.
24. Peavy K.M., Banta-Green C.J., Kingston S., Hanrahan M., Merrill J.O., Coffin P.O. "Hooked on" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J. Psychoactive Drugs 2012, 44:259-265.
25. Pollini R.A., Banta-Green C.J., Cuevas-Mota J., Metzner M., Teshale E., Garfein R.S. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst. Abuse Rehabil. 2011, 2:173-180.
26. Rossen L.M., Khan D., Warner M. Trends and geographic patterns in drug-poisoning death rates in the U.S., 1999-2009. Am. J. Prev. Med. 2013, 45:e19-e25.
27. Strang J., Bird S.M., Parmar M.K.B. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial. J. Urban Health 2013, 90:983-996.
28. Tassiopoulos K., Bernstein J., Bernstein E. Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study. Addict. Sci. Clin. Pract. 2013, 8:1-8.
29. Thorpe L.E., Bailey S.L., Huo D., Monterroso E.R., Ouellet L.J. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). J. Acquir. Immune. Defic. Syndr. 2001, 27:71-78.
30. US Department of Health and Human Services The TEDS Report: Injection Drug Abuse Admissions to Substance Abuse Treatment: 1992 and 2009 2011, USDHHS, Washington, DC.
31. Walley A.Y., Xuan Z., Hackman H.H., Quinn E., Doe-Simkins M., Sorensen-Alawad A., Ruiz S., Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013, 174:1-12.
32. Washington State Department of Health Washington State Healthy Youth Survey 2012 Analytic Report 2014, Washington State Department of Health, 〈http://www.doh.wa.gov/Portals/1/Documents/Pubs/160-193-HYS-AnalyticReport2012.pdf〉 (accessed on July 2 2014).
33. Wodak A., Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst. Use Misuse 2006, 41:777-813.